Recent evidence has demonstrated that MYC can dynamically drive a shift of master NETFs of SCLC from ASCL1 to NEUROD1 to YAP1 in the context of RB and p53 loss (Ireland et al., 2020). The gene discussed is ASCL1; the disease is small cell lung carcinoma.